First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer

被引：0
|
作者：
Hossein Taghizadeh
Matthias Unseld
Andreas Schmiderer
Angela Djanani
Klaus Wilthoner
Dieter Buchinger
Gerald W. Prager
机构：
[1] Medical University of Vienna,Clinical Division of Oncology, Department of Medicine I
[2] Comprehensive Cancer Center,Clinical Division of Gastroenterology, Hepatology and Metabolism, Department of Internal Medicine I
[3] Medical University Innsbruck,Clinical Division of Oncology, Department of Medicine I
[4] Salzkammergut Klinikum,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Biliary tract cancer; Chemotherapy; Nanoliposomal irinotecan; Progression-free survival; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 115
页数：6
相关论文
共 50 条
  • [21] Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
    Folprecht, G
    Lutz, MP
    Schöffski, P
    Seufferlein, T
    Nolting, A
    Pollert, P
    Köhne, CH
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 450 - 456
  • [22] Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    LANCET ONCOLOGY, 2022, 23 (01): : E11 - E11
  • [23] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [24] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [25] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
  • [26] A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium
    Verbruggen, Lise
    Verheggen, Lisa
    Vanhoutte, Greetje
    Loly, Catherine
    Lybaert, Willem
    Borbath, Ivan
    Vergauwe, Philippe
    Hendrickx, Koen
    Debeuckelaere, Celine
    de Haar-Holleman, Amy
    Van Laethem, Jean-Luc
    Peeters, Marc
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [27] A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium
    Verbruggen, Lise
    Verheggen, Lisa
    Vanhoutte, Greetje
    Loly, Catherine
    Lybaert, Willem
    Borbath, Ivan
    Vergauwe, Philippe
    Hendrickx, Koen
    Debeuckelaere, Celine
    de Haar-Holleman, Amy
    Van Laethem, Jean-Luc
    Peeters, Marc
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [28] Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study
    Raoul, Jean-Luc
    Van Laethem, Jean-Luc
    Peeters, Marc
    Brezault, Catherine
    Husseini, Fares
    Cals, Laurent
    Nippgen, Johannes
    Loos, Anja-Helena
    Rougier, Philippe
    BMC CANCER, 2009, 9
  • [29] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [30] TREATMENT OF ADVANCED COLORECTAL-CANCER WITH FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH CISPLATINUM
    SAGASTER, P
    ESSL, R
    TEICH, G
    FRITZ, E
    WASILEWSKI, M
    UMEK, H
    DUNSER, E
    MASCHER, H
    MICKSCHE, M
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1250 - 1254
12345